Both in Biotechnology
BioCardia vs Acumen Pharmaceuticals
Over the past year BCDA returned −31.3% and ABOS returned −88.9%; their daily moves had a correlation of 0.14.
BCDA −31.3% ABOS −88.9%Growth of $1, one year, split-adjusted
| Metric | BCDA | ABOS |
|---|---|---|
| Price | $0.9131 | $0.2163 |
| Market cap | $13.8M | $15.6M |
| Today | −0.92% | −7.72% |
| 1 month | −13.9% | −89.3% |
| 6 months | −17.7% | −91.6% |
| Year to date | −27.0% | −89.7% |
| 1 year | −34.3% | −90.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $4.1M | $52.3M |
| Dividend yield | — | — |
| Volatility (60d) | 68.9% | 492.9% |
| Short % of float | 6.2% | 7.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).